Skip to main content

Peer Review reports

From: Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen

Original Submission
30 Jun 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
11 Aug 2016 Editorially accepted
18 Aug 2016 Article published 10.1186/s12885-016-2711-5

You can find further information about peer review here.

Back to article page